Ran Chu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ran Chu has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Kun Song
Department of Obstetrics and Gynecology, QiLu Hospital of ShanDong University, JiNan, China
4 shared publications - Xiao Song
Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, China
4 shared publications Beihua Kong
Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China
3 shared publications- Shu Yao
Department of Obstetrics and Gynecology Qilu Hospital Cheeloo College of Medicine Shandong University Jinan Shandong China
3 shared publications Xiao Song
Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University Dezhou Hospital
3 shared publications- Beihua Kong
Department of Obstetrics and Gynecology, QiLu Hospital of ShanDong University, JiNan, China
2 shared publications
Latest Publications
- 26 September 2026
- Published by Elsevier in Surgical Oncology
- Vol. 69, 102579
Preoperative nutritional risk and clinically relevant postoperative complications in ovarian cancer patients undergoing cytoreductive surgery
- 26 September 2026
- Published by Elsevier in Surgical Oncology
- Vol. 69, 102579
Preoperative nutritional risk and clinically relevant postoperative complications in ovarian cancer patients undergoing cytoreductive surgery
- Open Access
- 22 August 2026
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 45 (1) , 2719498
Left ventricular hypertrophy as a predictor of adverse maternal and neonatal outcomes in chronic hypertension in pregnancy: a multicenter study
The impact of chronic hypertension (CHTN) combined with left ventricular hypertrophy (LVH) on adverse maternal and fetal pregnancy outcomes remains unclear. This multicenter retrospective cohort study included pregnant women with CHTN from four tertiary hospitals in China. Baseline characteristics were compared using the Kruskal-Wallis and Chi-squared tests with Bonferroni correction. Logistic regression (LR) identified risk factors for adverse outcomes. Four machine learning (ML) algorithms were validated, nomograms were developed for model visualization, and SHapley Additive exPlanations (SHAP) determined variable importance. Among 500 women, 117 (23.4%) had normal geometry, 118 (23.6%) concentric remodeling, 88 (17.6%) eccentric hypertrophy, and 177 (35.4%) concentric hypertrophy. Adverse maternal and fetal outcomes occurred in 126 (25.2%) and 359 (71.8%) women, respectively. LVH was independently associated with adverse maternal outcomes (OR 2.16, 95% CI 1.13-4.13) and fetal outcomes (OR 2.42, 95% CI 1.31-4.45). Additional maternal predictors included NYHA class III-IV, pre-eclampsia, oligohydramnios, elevated alanine aminotransferase and lactate dehydrogenase, hypoalbuminemia, greater bleeding loss, and blood transfusion. Fetal predictors included increased posterior wall thickness, oligohydramnios, abnormal umbilical artery flow, elevated alanine aminotransferase and blood urea nitrogen, low total protein, and proteinuria. ML models showed AUCs of 0.70-0.87 for maternal and 0.80-0.88 for fetal outcomes; SHAP identified LVH as an important contributor in both models. Early-pregnancy LVH was associated with higher risks of adverse maternal and fetal outcomes in women with CHTN. These models may support individualized risk stratification but require prospective external validation before clinical implementation.
- 22 August 2026
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 45 (1) , 2719498
Open AccessLeft ventricular hypertrophy as a predictor of adverse maternal and neonatal outcomes in chronic hypertension in pregnancy: a multicenter study
The impact of chronic hypertension (CHTN) combined with left ventricular hypertrophy (LVH) on adverse maternal and fetal pregnancy outcomes remains unclear. This multicenter retrospective cohort study included pregnant women with CHTN from four tertiary hospitals in China. Baseline characteristics were compared using the Kruskal-Wallis and Chi-squared tests with Bonferroni correction. Logistic regression (LR) identified risk factors for adverse outcomes. Four machine learning (ML) algorithms were validated, nomograms were developed for model visualization, and SHapley Additive exPlanations (SHAP) determined variable importance. Among 500 women, 117 (23.4%) had normal geometry, 118 (23.6%) concentric remodeling, 88 (17.6%) eccentric hypertrophy, and 177 (35.4%) concentric hypertrophy. Adverse maternal and fetal outcomes occurred in 126 (25.2%) and 359 (71.8%) women, respectively. LVH was independently associated with adverse maternal outcomes (OR 2.16, 95% CI 1.13-4.13) and fetal outcomes (OR 2.42, 95% CI 1.31-4.45). Additional maternal predictors included NYHA class III-IV, pre-eclampsia, oligohydramnios, elevated alanine aminotransferase and lactate dehydrogenase, hypoalbuminemia, greater bleeding loss, and blood transfusion. Fetal predictors included increased posterior wall thickness, oligohydramnios, abnormal umbilical artery flow, elevated alanine aminotransferase and blood urea nitrogen, low total protein, and proteinuria. ML models showed AUCs of 0.70-0.87 for maternal and 0.80-0.88 for fetal outcomes; SHAP identified LVH as an important contributor in both models. Early-pregnancy LVH was associated with higher risks of adverse maternal and fetal outcomes in women with CHTN. These models may support individualized risk stratification but require prospective external validation before clinical implementation.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-11
Impact of Antepartum Anemia on Maternal and Perinatal Outcomes in Women with Placenta Accreta Spectrum: A Multicenter Study
Purpose: To evaluate whether antepartum anemia is associated with adverse maternal and perinatal outcomes in women with placenta accreta spectrum (PAS). Patients and Methods: This multicenter retrospective study included 984 women with PAS from three Chinese tertiary hospitals between September 2016 and July 2025. Eligible participants had singleton pregnancies and delivered at ≥ 28 weeks. PAS was confirmed by failure of spontaneous placental separation during delivery or by pathology. Anemia was defined as hemoglobin < 110 g/L. To minimize baseline imbalance, propensity score matching was performed using a 1:1 nearest neighbor matching algorithm with a caliper width of 0.2. Group comparisons used the Chi-square, Fisher’s exact, or Mann–Whitney U test. Univariable and multivariable logistic regression identified independent risk factors for adverse outcomes. Results: Among 984 participants, the incidence of anemia was 32.1%. Anemia group had higher rates of severe PAS subtypes, placenta previa, and vaginal bleeding. The matched analysis included 277 women per group, and the main residual difference was transfusion requirement (median 4 vs 2 units, P < 0.001) and composite adverse maternal outcome (P = 0.006). Multivariable analysis identified anemia as an independent risk factor for adverse maternal outcomes (OR 1.84, 95% CI 1.22– 2.78, P = 0.004). Other independent risk factors included placenta increta/percreta (OR 25.56) and ultrasound signs. Anemia was not associated with adverse perinatal outcomes. Protective factors for perinatal outcomes included longer gestation (OR 0.65) and cesarean delivery (OR 0.01), whereas emergency delivery increased risk (OR 3.75). Conclusion: In women with PAS, antepartum anemia is associated with increased adverse maternal risk, especially transfusion requirements. This supports attention to anemia screening and optimization in PAS care pathways, which may reduce blood resource burden in resource-limited regions. When antepartum anemia cannot be adequately corrected before delivery, sufficient blood preparation is essential.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-11
Open AccessImpact of Antepartum Anemia on Maternal and Perinatal Outcomes in Women with Placenta Accreta Spectrum: A Multicenter Study
Purpose: To evaluate whether antepartum anemia is associated with adverse maternal and perinatal outcomes in women with placenta accreta spectrum (PAS). Patients and Methods: This multicenter retrospective study included 984 women with PAS from three Chinese tertiary hospitals between September 2016 and July 2025. Eligible participants had singleton pregnancies and delivered at ≥ 28 weeks. PAS was confirmed by failure of spontaneous placental separation during delivery or by pathology. Anemia was defined as hemoglobin < 110 g/L. To minimize baseline imbalance, propensity score matching was performed using a 1:1 nearest neighbor matching algorithm with a caliper width of 0.2. Group comparisons used the Chi-square, Fisher’s exact, or Mann–Whitney U test. Univariable and multivariable logistic regression identified independent risk factors for adverse outcomes. Results: Among 984 participants, the incidence of anemia was 32.1%. Anemia group had higher rates of severe PAS subtypes, placenta previa, and vaginal bleeding. The matched analysis included 277 women per group, and the main residual difference was transfusion requirement (median 4 vs 2 units, P < 0.001) and composite adverse maternal outcome (P = 0.006). Multivariable analysis identified anemia as an independent risk factor for adverse maternal outcomes (OR 1.84, 95% CI 1.22– 2.78, P = 0.004). Other independent risk factors included placenta increta/percreta (OR 25.56) and ultrasound signs. Anemia was not associated with adverse perinatal outcomes. Protective factors for perinatal outcomes included longer gestation (OR 0.65) and cesarean delivery (OR 0.01), whereas emergency delivery increased risk (OR 3.75). Conclusion: In women with PAS, antepartum anemia is associated with increased adverse maternal risk, especially transfusion requirements. This supports attention to anemia screening and optimization in PAS care pathways, which may reduce blood resource burden in resource-limited regions. When antepartum anemia cannot be adequately corrected before delivery, sufficient blood preparation is essential.
- Open Access
- 1 February 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
High-Risk Clinical Characteristics and Risk Model for Unexpected Cervical Cancer Diagnosed After Surgery in Patients with LSIL/HSIL Biopsy
Background: Women with colposcopy-directed biopsy results of low-grade or high-grade squamous intraepithelial lesion (LSIL/HSIL) who are subsequently found to have cervical cancer after surgery likely represent missed preoperative malignancy. This study aims to identify risk factors associated with these missed diagnoses and to develop a preoperative risk prediction model. Methods: Patients with LSIL/HSIL on colposcopy-directed biopsy who underwent cervical conization or hysterectomy at a single center were retrospectively included. Postoperative cervical cancer was the adverse outcome. Baseline characteristics were compared using chi-square tests. Predictors were identified by univariate and multivariable logistic regression to build a logistic regression model. Internal validation applied machine learning with five-fold cross-validation. Performance was evaluated by receiver operating characteristic (ROC) curve (AUC) and accuracy, with discrimination, calibration, and clinical utility assessed using ROC curves, calibration plots, and decision curve analysis (DCA). Results: A total of 1271 patients were included, and 79 were diagnosed with cervical cancer after surgery. Risk factors significantly associated with postoperative cervical cancer diagnosis included age (OR, 1.0; 95% CI, 1.0– 1.0, p=0.045), gravidity (OR, 1.2; 95% CI, 1.1– 1.3, p < 0.001), human papillomavirus 16 or 18 infection (OR, 2.6; 95% CI, 1.4– 4.6, p=0.002), colposcope biopsy site numbers ≥ 4 (OR, 0.2; 95% CI, 0.1– 0.3, p < 0.001), ThinPrep Cytologic Test indicates high-grade squamous intraepithelial lesion (OR, 3.1; 95% CI, 1.1– 8.5, p=0.028), and neutrophil-to-lymphocyte ratio (OR, 1.1; 95% CI, 1.0– 1.3, p=0.015). In five-fold cross-validation, the machine learning algorithms yielded an AUC of 0.72– 0.81 and an accuracy of 0.93– 0.94 for the model. ROC curves, calibration curves, and DCA analysis demonstrate the model’s excellent predictive capability and performance. Conclusion: This study developed and internally validated a clinical prediction model to estimate the preoperative risk of occult cervical cancer in patients with LSIL/HSIL on colposcopy-directed biopsy. This model may support risk-stratified surgical decision-making and help reduce missed diagnoses. Plain Language Summary: In clinical practice, a proportion of people with cervical cancer are still missed by colposcopy-guided biopsy. Some individuals receive a colposcopy-guided biopsy diagnosis of low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL), but are subsequently found to have invasive cervical cancer only after cervical conization or hysterectomy. Such missed diagnoses may delay appropriate treatment and adversely affect prognosis. This study retrospectively analyzed 1271 patients whose colposcopy-guided biopsies suggested LSIL or HSIL and who later underwent loop electrosurgical excision procedure, cold knife conization, or hysterectomy at a tertiary center. Among these patients, 79 were diagnosed with cervical cancer. Baseline clinical characteristics were compared between those with and without cervical cancer, and logistic regression analysis was used to identify high-risk clinical factors and to construct a nomogram-based risk assessment model. Older age, higher gravidity, human papillomavirus infection, abnormal ThinPrep Cytologic Test results, increased neutrophil-to-lymphocyte ratio, and the number of colposcopic biopsy sites were associated with a higher likelihood of postoperative diagnosis of cervical cancer. These factors were integrated into a clinical prediction model that showed good ability to distinguish between individuals with and without occult cervical cancer, with favourable calibration and potential clinical utility. These findings suggest that colposcopy and biopsy result alone may be insufficient to reliably exclude early cervical cancer. Applying this risk prediction model alongside routine clinical and laboratory information may help clinicians to identify individuals at higher risk of occult cervical cancer, optimize preoperative surgical planning, reduce missed diagnoses, and improve management of cervical lesions.
- 1 February 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
Open AccessHigh-Risk Clinical Characteristics and Risk Model for Unexpected Cervical Cancer Diagnosed After Surgery in Patients with LSIL/HSIL Biopsy
Background: Women with colposcopy-directed biopsy results of low-grade or high-grade squamous intraepithelial lesion (LSIL/HSIL) who are subsequently found to have cervical cancer after surgery likely represent missed preoperative malignancy. This study aims to identify risk factors associated with these missed diagnoses and to develop a preoperative risk prediction model. Methods: Patients with LSIL/HSIL on colposcopy-directed biopsy who underwent cervical conization or hysterectomy at a single center were retrospectively included. Postoperative cervical cancer was the adverse outcome. Baseline characteristics were compared using chi-square tests. Predictors were identified by univariate and multivariable logistic regression to build a logistic regression model. Internal validation applied machine learning with five-fold cross-validation. Performance was evaluated by receiver operating characteristic (ROC) curve (AUC) and accuracy, with discrimination, calibration, and clinical utility assessed using ROC curves, calibration plots, and decision curve analysis (DCA). Results: A total of 1271 patients were included, and 79 were diagnosed with cervical cancer after surgery. Risk factors significantly associated with postoperative cervical cancer diagnosis included age (OR, 1.0; 95% CI, 1.0– 1.0, p=0.045), gravidity (OR, 1.2; 95% CI, 1.1– 1.3, p < 0.001), human papillomavirus 16 or 18 infection (OR, 2.6; 95% CI, 1.4– 4.6, p=0.002), colposcope biopsy site numbers ≥ 4 (OR, 0.2; 95% CI, 0.1– 0.3, p < 0.001), ThinPrep Cytologic Test indicates high-grade squamous intraepithelial lesion (OR, 3.1; 95% CI, 1.1– 8.5, p=0.028), and neutrophil-to-lymphocyte ratio (OR, 1.1; 95% CI, 1.0– 1.3, p=0.015). In five-fold cross-validation, the machine learning algorithms yielded an AUC of 0.72– 0.81 and an accuracy of 0.93– 0.94 for the model. ROC curves, calibration curves, and DCA analysis demonstrate the model’s excellent predictive capability and performance. Conclusion: This study developed and internally validated a clinical prediction model to estimate the preoperative risk of occult cervical cancer in patients with LSIL/HSIL on colposcopy-directed biopsy. This model may support risk-stratified surgical decision-making and help reduce missed diagnoses. Plain Language Summary: In clinical practice, a proportion of people with cervical cancer are still missed by colposcopy-guided biopsy. Some individuals receive a colposcopy-guided biopsy diagnosis of low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL), but are subsequently found to have invasive cervical cancer only after cervical conization or hysterectomy. Such missed diagnoses may delay appropriate treatment and adversely affect prognosis. This study retrospectively analyzed 1271 patients whose colposcopy-guided biopsies suggested LSIL or HSIL and who later underwent loop electrosurgical excision procedure, cold knife conization, or hysterectomy at a tertiary center. Among these patients, 79 were diagnosed with cervical cancer. Baseline clinical characteristics were compared between those with and without cervical cancer, and logistic regression analysis was used to identify high-risk clinical factors and to construct a nomogram-based risk assessment model. Older age, higher gravidity, human papillomavirus infection, abnormal ThinPrep Cytologic Test results, increased neutrophil-to-lymphocyte ratio, and the number of colposcopic biopsy sites were associated with a higher likelihood of postoperative diagnosis of cervical cancer. These factors were integrated into a clinical prediction model that showed good ability to distinguish between individuals with and without occult cervical cancer, with favourable calibration and potential clinical utility. These findings suggest that colposcopy and biopsy result alone may be insufficient to reliably exclude early cervical cancer. Applying this risk prediction model alongside routine clinical and laboratory information may help clinicians to identify individuals at higher risk of occult cervical cancer, optimize preoperative surgical planning, reduce missed diagnoses, and improve management of cervical lesions.
- Open Access
- 3 September 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1539998
Risk factors for emergency cesarean delivery in patients with placenta accreta spectrum: a multicenter retrospective cohort study
Background: Pregnant women with placenta accreta spectrum (PAS), particularly those with placenta increta or placenta percreta, undergoing emergency cesarean section are at a high risk of excessive intraoperative hemorrhage and related complications. This study aimed to evaluate maternal and neonatal outcomes and to identify risk factors associated with emergency cesarean section in women with PAS.Methods: A multicenter retrospective cohort study was conducted, including PAS patients who underwent cesarean section at three tertiary hospitals between January 2016 and January 2023. After 1:1 propensity score matching (PSM), clinical characteristics were compared between the emergency and elective cesarean section groups using chi-square tests and nonparametric rank-sum tests. Risk factors for emergency cesarean section were identified through Cox proportional hazards regression analysis.Results: Among 299 patients included in the study, 78 were selected for analysis after PSM. In the matched cohort, patients in the emergency cesarean section group required significantly more packed red blood cell transfusions (p = 0.034), had a higher rate of ascending branch ligation of the uterine artery (p < 0.001), required more neonatal intensive care unit admissions (p = 0.041), and delivered neonates with lower birth weight (p = 0.044). Key risk factors for emergency cesarean section included a history of more than one prior cesarean section [hazard ratio (HR), 2.34; 95% confidence intervals (CI): 1.24–4.42], preoperative hemoglobin levels ≤100 g/L (HR, 2.28; 95% CI: 1.19–4.40), preeclampsia (HR, 2.93; 95% CI, 1.10–7.82), and vascular lacunae within the placenta (HR, 0.40; 95% CI, 0.21–0.76).Conclusion: Emergency cesarean section in PAS patients is associated with increased transfusion requirements and adverse neonatal outcomes. Close monitoring and enhanced management of patients with identified risk factors may help improve maternal and neonatal outcomes.
- 3 September 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1539998
Open AccessRisk factors for emergency cesarean delivery in patients with placenta accreta spectrum: a multicenter retrospective cohort study
Background: Pregnant women with placenta accreta spectrum (PAS), particularly those with placenta increta or placenta percreta, undergoing emergency cesarean section are at a high risk of excessive intraoperative hemorrhage and related complications. This study aimed to evaluate maternal and neonatal outcomes and to identify risk factors associated with emergency cesarean section in women with PAS.Methods: A multicenter retrospective cohort study was conducted, including PAS patients who underwent cesarean section at three tertiary hospitals between January 2016 and January 2023. After 1:1 propensity score matching (PSM), clinical characteristics were compared between the emergency and elective cesarean section groups using chi-square tests and nonparametric rank-sum tests. Risk factors for emergency cesarean section were identified through Cox proportional hazards regression analysis.Results: Among 299 patients included in the study, 78 were selected for analysis after PSM. In the matched cohort, patients in the emergency cesarean section group required significantly more packed red blood cell transfusions (p = 0.034), had a higher rate of ascending branch ligation of the uterine artery (p < 0.001), required more neonatal intensive care unit admissions (p = 0.041), and delivered neonates with lower birth weight (p = 0.044). Key risk factors for emergency cesarean section included a history of more than one prior cesarean section [hazard ratio (HR), 2.34; 95% confidence intervals (CI): 1.24–4.42], preoperative hemoglobin levels ≤100 g/L (HR, 2.28; 95% CI: 1.19–4.40), preeclampsia (HR, 2.93; 95% CI, 1.10–7.82), and vascular lacunae within the placenta (HR, 0.40; 95% CI, 0.21–0.76).Conclusion: Emergency cesarean section in PAS patients is associated with increased transfusion requirements and adverse neonatal outcomes. Close monitoring and enhanced management of patients with identified risk factors may help improve maternal and neonatal outcomes.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Therapeutic Advances in Reproductive Health
- Vol. 19
Development of a predictive model for severe peripartum hemorrhage in placenta accreta spectrum cases under neuraxial anesthesia: a multicenter retrospective analysis
Background: The placenta accreta spectrum (PAS) represents a significant risk factor for severe postpartum hemorrhage. Recent studies have demonstrated the safety of neuraxial anesthesia (NA) in cesarean delivery (CD) for patients with PAS. Objectives: To evaluate the risk of severe peripartum hemorrhage in patients with PAS who underwent CD under NA. Design: A multicenter retrospective cohort study. Methods: This study analyzed 214 patients diagnosed with PAS. Logistic regression was used to identify factors increasing the risk of severe peripartum hemorrhage. A total of six machine learning (ML) algorithms were employed for model validation. Results: The predictive model includes the following risk factors: age at delivery >33 years ( p = 0.004), history of CD >1 ( p = 0.020), preoperative HGB ⩽ 100 g/L ( p = 0.013), placenta previa classification ( p = 0.001), vascular lacunae within the placenta ( p = 0.015), and labor duration ( p = 0.026). The validation of ML algorithms revealed that the model achieved an accuracy ranging from 0.68 to 0.71, with an area under the receiver operating characteristic curve between 0.75 and 0.79. A nomogram list and web-based calculator were constructed for clinical implementation, and a risk stratification system was established based on model scores. Conclusion: A prenatal risk assessment model was developed to estimate the likelihood of severe peripartum hemorrhage in PAS patients undergoing CD under NA. This model may provide preliminary support for clinicians in tailoring anesthetic management strategies for potentially high-risk cases, but further studies are needed to confirm its clinical utility.
- 1 January 2025
- Published by SAGE Publications in Therapeutic Advances in Reproductive Health
- Vol. 19
Open AccessDevelopment of a predictive model for severe peripartum hemorrhage in placenta accreta spectrum cases under neuraxial anesthesia: a multicenter retrospective analysis
Background: The placenta accreta spectrum (PAS) represents a significant risk factor for severe postpartum hemorrhage. Recent studies have demonstrated the safety of neuraxial anesthesia (NA) in cesarean delivery (CD) for patients with PAS. Objectives: To evaluate the risk of severe peripartum hemorrhage in patients with PAS who underwent CD under NA. Design: A multicenter retrospective cohort study. Methods: This study analyzed 214 patients diagnosed with PAS. Logistic regression was used to identify factors increasing the risk of severe peripartum hemorrhage. A total of six machine learning (ML) algorithms were employed for model validation. Results: The predictive model includes the following risk factors: age at delivery >33 years ( p = 0.004), history of CD >1 ( p = 0.020), preoperative HGB ⩽ 100 g/L ( p = 0.013), placenta previa classification ( p = 0.001), vascular lacunae within the placenta ( p = 0.015), and labor duration ( p = 0.026). The validation of ML algorithms revealed that the model achieved an accuracy ranging from 0.68 to 0.71, with an area under the receiver operating characteristic curve between 0.75 and 0.79. A nomogram list and web-based calculator were constructed for clinical implementation, and a risk stratification system was established based on model scores. Conclusion: A prenatal risk assessment model was developed to estimate the likelihood of severe peripartum hemorrhage in PAS patients undergoing CD under NA. This model may provide preliminary support for clinicians in tailoring anesthetic management strategies for potentially high-risk cases, but further studies are needed to confirm its clinical utility.
- Open Access
- 1 January 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 21-32
Association of Adverse Perinatal Outcomes with Blood Components Transfusion in Patients with Acute Fatty Liver of Pregnancy
Purpose: To investigate the rare obstetric emergency with no specific treatments called acute fatty liver of pregnancy. The primary objective was to evaluate association of adverse perinatal outcomes with blood components transfusion. While the secondary objective focused on further establishing the predictive risk factors for adverse perinatal outcomes. Participants and Methods: This retrospective cohort study included patients, who diagnosed with acute fatty liver of pregnancy without hepatic/malignant diseases in Qilu Hospital of Shandong University over 12-year period (collected 2007– 2019, aged 20– 41years). Chi-square test was used to explore the relevance between blood transfusion therapy and adverse perinatal outcomes. Meanwhile, logistic regression analysis was performed to identify predictive risk factors. Results: Of 146 patients, 26 (26/146, 17.8%) received prenatal blood transfusions. These patients had reduced gestational ages and exhibited more severe clinical symptoms. The association between blood transfusion and adverse maternal outcomes yielded a P value of 0.044, while the association with fetal outcomes was highly significant (P< 0.001). Multivariate logistic regression analysis identified seven high-risk factors for maternal outcomes and six for fetal outcomes, all demonstrating strong discriminatory capacity. Conclusion: Blood component transfusion may serve as a marker of disease severity. Prompt identification of patients with high-risk factors is crucial to improve maternal and fetal outcomes. Plain Language Summary: This retrospective study evaluated 146 patients with acute fatty liver of pregnancy and 172 fetuses to determine the effectiveness of blood transfusion therapy and identify predictive risk factors for adverse outcomes. Dr. Li’s and Zhang’s team found that patients who received blood transfusions exhibited more severe symptoms. Seven high-risk factors for maternal outcomes and six for fetal outcomes were identified. Blood transfusion therapy may act as an early indicator of disease severity, requiring immediate intervention for both mothers and fetuses with high-risk factors.
- 1 January 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 21-32
Open AccessAssociation of Adverse Perinatal Outcomes with Blood Components Transfusion in Patients with Acute Fatty Liver of Pregnancy
Purpose: To investigate the rare obstetric emergency with no specific treatments called acute fatty liver of pregnancy. The primary objective was to evaluate association of adverse perinatal outcomes with blood components transfusion. While the secondary objective focused on further establishing the predictive risk factors for adverse perinatal outcomes. Participants and Methods: This retrospective cohort study included patients, who diagnosed with acute fatty liver of pregnancy without hepatic/malignant diseases in Qilu Hospital of Shandong University over 12-year period (collected 2007– 2019, aged 20– 41years). Chi-square test was used to explore the relevance between blood transfusion therapy and adverse perinatal outcomes. Meanwhile, logistic regression analysis was performed to identify predictive risk factors. Results: Of 146 patients, 26 (26/146, 17.8%) received prenatal blood transfusions. These patients had reduced gestational ages and exhibited more severe clinical symptoms. The association between blood transfusion and adverse maternal outcomes yielded a P value of 0.044, while the association with fetal outcomes was highly significant (P< 0.001). Multivariate logistic regression analysis identified seven high-risk factors for maternal outcomes and six for fetal outcomes, all demonstrating strong discriminatory capacity. Conclusion: Blood component transfusion may serve as a marker of disease severity. Prompt identification of patients with high-risk factors is crucial to improve maternal and fetal outcomes. Plain Language Summary: This retrospective study evaluated 146 patients with acute fatty liver of pregnancy and 172 fetuses to determine the effectiveness of blood transfusion therapy and identify predictive risk factors for adverse outcomes. Dr. Li’s and Zhang’s team found that patients who received blood transfusions exhibited more severe symptoms. Seven high-risk factors for maternal outcomes and six for fetal outcomes were identified. Blood transfusion therapy may act as an early indicator of disease severity, requiring immediate intervention for both mothers and fetuses with high-risk factors.
- 8 March 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (4) , 108261
Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study
- 8 March 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (4) , 108261
Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study
- 12 February 2024
- Published by Springer Nature in Journal of Anesthesia
- Vol. 38 (2) , 167-178
Perinatal outcomes comparison between neuraxial and general anesthesia in pregnant women with placenta accreta spectrum: a multicenter retrospective study
Purpose We investigated the impact of anesthesia mode on perinatal outcomes in patients with placenta accreta spectrum (PAS) undergoing cesarean delivery and identified factors associated with adverse perinatal events. Methods The multicenter retrospective analysis was conducted in patients with PAS who delivered at three medical centers. Patients were classified according to whether they received general anesthesia (GA) or neuraxial anesthesia (NA). We compared the basic clinical characteristics of patients in the pre-propensity score matching (PSM) and post-PSM cohorts and identified factors associated with a high risk of adverse maternal outcomes. Results This study included a total of 425 patients, with 307 (72.2%) in the GA group and 118 (27.8%) in the NA group. After PSM, 162 patients were identified for analysis. In the post-matched cohort, the NA group exhibited shorter total operation time (P = 0.030) and postoperative length of hospital stay (P = 0.037). Additionally, the NA group experienced lower intraoperative blood loss (P < 0.001) and received fewer units of transfused packed red blood cells (PRBC) (P < 0.001). Multivariate logistic regression analysis indicated that GA (P < 0.001), emergency cesarean delivery (P = 0.010), vascular lacunae within the placenta (P < 0.001), hypervascularity of uterine-placental margin (P = 0.002), hypervascularity of the cervix (P = 0.014), and balloon placement in the abdominal aorta (P < 0.001) were associated with a high risk of adverse maternal events. Conclusion In comparison to GA, cesarean delivery with NA in PAS patients appears to be associated with reduced intraoperative blood loss, PRBC transfusion, operating duration, and postoperative hospital stay.
- 12 February 2024
- Published by Springer Nature in Journal of Anesthesia
- Vol. 38 (2) , 167-178
Perinatal outcomes comparison between neuraxial and general anesthesia in pregnant women with placenta accreta spectrum: a multicenter retrospective study
Purpose We investigated the impact of anesthesia mode on perinatal outcomes in patients with placenta accreta spectrum (PAS) undergoing cesarean delivery and identified factors associated with adverse perinatal events. Methods The multicenter retrospective analysis was conducted in patients with PAS who delivered at three medical centers. Patients were classified according to whether they received general anesthesia (GA) or neuraxial anesthesia (NA). We compared the basic clinical characteristics of patients in the pre-propensity score matching (PSM) and post-PSM cohorts and identified factors associated with a high risk of adverse maternal outcomes. Results This study included a total of 425 patients, with 307 (72.2%) in the GA group and 118 (27.8%) in the NA group. After PSM, 162 patients were identified for analysis. In the post-matched cohort, the NA group exhibited shorter total operation time (P = 0.030) and postoperative length of hospital stay (P = 0.037). Additionally, the NA group experienced lower intraoperative blood loss (P < 0.001) and received fewer units of transfused packed red blood cells (PRBC) (P < 0.001). Multivariate logistic regression analysis indicated that GA (P < 0.001), emergency cesarean delivery (P = 0.010), vascular lacunae within the placenta (P < 0.001), hypervascularity of uterine-placental margin (P = 0.002), hypervascularity of the cervix (P = 0.014), and balloon placement in the abdominal aorta (P < 0.001) were associated with a high risk of adverse maternal events. Conclusion In comparison to GA, cesarean delivery with NA in PAS patients appears to be associated with reduced intraoperative blood loss, PRBC transfusion, operating duration, and postoperative hospital stay.